The management and prognosis of pulmonary hypertension heavily relies on whether the pathology is localized in pulmonary arteries or veins. In particular, at early stages, it is challenging to distinguish pulmonary arterial hypertension (PAH) from the rare subtype of pulmonary veno-occlusive disease (PVOD) because clinical presentations of PAH and PVOD can be similar. A new study in The American Journal of Pathology, published by Elsevier, reports gene expression analysis of lung explant tissue can accurately differentiate PAH from PVOD.
- Novel method for measuring spatial dependencies turns less data into more data
- Smile, wave: Some exoplanets may be able to see us, too
- Observed COVID-19 variability may have underlying molecular sources
- Genome archeologists discover path to activate immune response against cancer
- At our cores, we’re all strengthened by ‘dumbbells’